An ISO-certified genomics workflow for identification and surveillance of antimicrobial resistance
05 January 2023
Realising the promise of genomics to revolutionise identification and surveillance of antimicrobial resistance (AMR) has been a long-standing challenge in clinical and public health microbiology. Here, we report the creation and validation of abritAMR, an ISO-certified bioinformatics platform for genomics-based bacterial AMR gene detection. The abritAMR platform utilises NCBI’s AMRFinderPlus, as well as additional features that classify AMR determinants into antibiotic classes and provide customised reports.
Further reading: Nature Communications
Author(s): Norelle L. Sherry, Kristy A. Horan, Susan A. Ballard, Anders Gonҫalves da Silva, Claire L. Gorrie, Mark B. Schultz, Kerrie Stevens, Mary Valcanis, Michelle L. Sait, Timothy P. Stinear, Benjamin P. Howden & Torsten Seemann
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
